Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom right of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).
Please find information on our services and visiting restrictions in our COVID-19 section.
Patients and visitors must wear a face covering in our hospitals.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
The direction of research is often set by researchers or by the drug industry. We want to enable patients, carers, family members, and the health and social care professionals who look after those with bipolar to have their say, so that future research is aligned with what matters to everyone whose life is affected by bipolar disorder.
The James Lind Alliance (JLA) process brings patient, carer, family member and clinician groups together on an equal footing in a Priority Setting Partnership to:
Our Project Protocol document set out the aims, objectives and commitments of the Bipolar PSP. It set out how the project meets the principles established by the JLA. Our JLA Adviser played a central role in helping the Steering Group establish this protocol and worked to ensure that accountability and transparency were maintained throughout the project.